# FDA recall Z-2044-2023

> **Appliedvr** · Class II · device recall initiated 2023-02-27.

## Product

RelieVR REF: RVX-2002, Rx Only.  Virtual reality behavioral therapy device for pain relief.

## Reason for recall

There is the potential for the program software to malfunction which will not allow it to move forward to the next session.

## Distribution

US: NY OUS: None

## Key facts

- **Recall number:** Z-2044-2023
- **Recalling firm:** Appliedvr
- **Classification:** Class II
- **Product type:** device
- **Status:** Completed
- **Initiation date:** 2023-02-27
- **Report date:** 2023-07-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Van Nuys, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2044-2023

## Citation

> AI Analytics. FDA recall Z-2044-2023. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/Z-2044-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*